2bc7

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 7: Line 7:
|ACTIVITY=
|ACTIVITY=
|GENE=
|GENE=
 +
|DOMAIN=
 +
|RELATEDENTRY=[[2bc8|2BC8]]
 +
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2bc7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2bc7 OCA], [http://www.ebi.ac.uk/pdbsum/2bc7 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2bc7 RCSB]</span>
}}
}}
Line 26: Line 29:
[[Category: helix]]
[[Category: helix]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 16:00:00 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 02:04:12 2008''

Revision as of 23:04, 30 March 2008


PDB ID 2bc7

Drag the structure with the mouse to rotate
Related: 2BC8


Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml



Solution structure of [Sec2,8]-ImI


Overview

Disulfide bonds are important structural motifs that play an essential role in maintaining the conformational stability of many bioactive peptides. Of particular importance are the conotoxins, which selectively target a wide range of ion channels that are implicated in numerous disease states. Despite the enormous potential of conotoxins as therapeutics, their multiple disulfide bond frameworks are inherently unstable under reducing conditions. Reduction or scrambling by thiol-containing molecules such as glutathione or serum albumin in intracellular or extracellular environments such as blood plasma can decrease their effectiveness as drugs. To address this issue, we describe a new class of selenoconotoxins where cysteine residues are replaced by selenocysteine to form isosteric and nonreducible diselenide bonds. Three isoforms of alpha-conotoxin ImI were synthesized by t-butoxycarbonyl chemistry with systematic replacement of one ([Sec(2,8)]ImI or [Sec(3,12)]ImI), or both ([Sec(2,3,8,12)]ImI) disulfide bonds with a diselenide bond. Each analogue demonstrated remarkable stability to reduction or scrambling under a range of chemical and biological reducing conditions. Three-dimensional structural characterization by NMR and CD spectroscopy indicates conformational preferences that are very similar to those of native ImI, suggesting fully isomorphic structures. Additionally, full bioactivity was retained at the alpha7 nicotinic acetylcholine receptor, with each selenoanalogue exhibiting a dose-response curve that overlaps with wild-type ImI, thus further supporting an isomorphic structure. These results demonstrate that selenoconotoxins can be used as highly stable scaffolds for the design of new drugs.

About this Structure

2BC7 is a Single protein structure of sequence from [1]. Full crystallographic information is available from OCA.

Reference

Alpha-selenoconotoxins, a new class of potent alpha7 neuronal nicotinic receptor antagonists., Armishaw CJ, Daly NL, Nevin ST, Adams DJ, Craik DJ, Alewood PF, J Biol Chem. 2006 May 19;281(20):14136-43. Epub 2006 Feb 24. PMID:16500898

Page seeded by OCA on Mon Mar 31 02:04:12 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools